The Journal of Arthroplasty
Volume 25, Issue 2 , Pages 173-178, February 2010

Fifteen-Year to 19-Year Follow-Up of the Insall-Burstein-1 Total Knee Arthroplasty

  • Ayesha R. Abdeen, MD, FRCSC

      Affiliations

    • Department of Orthopaedic Surgery, University of Southern California, Keck School of Medicine, Los Angeles, California
    • Corresponding Author InformationReprint requests: Ayesha R. Abdeen, MD, FRCSC, Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Stoneman 10, Boston, MA 02215.
    • ,
  • Stacy B. Collen, BSc

      Affiliations

    • Department of Statistics, University of Southern California, Los Angeles, California
    • ,
  • Kelly G. Vince, MD, FRCSC

      Affiliations

    • Department of Orthopaedic Surgery, University of Southern California, Keck School of Medicine, Los Angeles, California

Received 7 January 2008; accepted 10 January 2009. published online 06 February 2009.

Abstract 

This represents a 15-year to 19-year follow-up of 100 Insall-Burstein-I posterior-stabilized knee prostheses implanted in 86 patients from 1986 to 1989 and originally reported at 10 to 12 years (Thadani et al, 2000). In the original cohort, 6 failures occurred by 10 years. At 15 to 19 years, 55 patients (66 knees) had died; 18 patients were followed with clinical examination and radiographs, and 11 by telephone; 3 knees in 2 patients were lost. There were no new failures or additional surgeries from 10 to 19 years. Three knees exhibited osteolytic lesions. No case required revision due to symptomatic osteolysis or polyethylene wear. Using revision as end point, survival was 92.4% at 19 years. In summary, the prosthesis is likely to outlive the patients when classic indications for age and activity are respected.

Keywords: primary knee arthroplasty, long-term follow-up, survivorship, Insall-Burstein-1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No benefits or funds were received in support of the study.

 Level of evidence: therapeutic level IV.

PII: S0883-5403(09)00015-1

doi:10.1016/j.arth.2009.01.009

Refers to erratum:

  • Erratum

    Ayesha R. Abdeen
    The Journal of Arthroplasty August 2011 (Vol. 26, Issue 5, Page 824)

The Journal of Arthroplasty
Volume 25, Issue 2 , Pages 173-178, February 2010

Article Tools

* Image Usage & Resolution